Ad www.AngelOne.in
FREE Account Opening + Zero AMC Fees* + MutualFund SIP1
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Ad www.AngelOne.in
SME IPO Status: Listed [17th May 2023 to 19th May 2023]
Remus Pharmaceuticals Limited offers an SME IPO issue size of 388,000 equity shares worth up to Rs 47.69 Cr. The subscription for this SME IPO is opening from 17 May 2023 to 19 May 2023. The face value of the equity share is Rs 10 per share. And the issue price band for this SME IPO is ranging from Rs 1150 to Rs 1229 per share along with the lot size of 100 shares and its multiple.
Stay updated with us to know more about the Remus Pharmaceuticals Limited IPO Review including company overview, financial, live subscription, allotment, GMP, and more.
| SME IPO Issue Opening Date: | 17th May 2023 |
| SME IPO Issue Closing Date: | 19th May 2023 |
| SME IPO Issue Price: | ₹1150-1229 Per Share |
| DRHP: | Download DRHP |
| RHP: | Download RHP |
| Anchor List: | Download Anchor List |
| IPO Listing At: | NSE SME |
| Retail Quota: | Not less than 35% of the Net Issue |
| SME IPO Issue Type: | Book Build Issue |
| SME IPO Issue Size: | ₹47.69 Cr |
| Fresh Issue: | ₹47.69 Cr |
| Face Value: | ₹10 Per Equity Share |
| SME IPO Discount: | TBD |
| Promoter Holding Pre IPO: | 92.82% |
| Promoter Holding Post IPO: | 68.37% |
| Allotment Status: | Allotment Status |
| NSE Code: | REMUS |
Get important updates regarding Remus Pharmaceuticals SME IPO tentative timeline covering SME IPO opening, closing, allotment, and listing dates. Dates are updated as they are announced.
| SME IPO Activity | Date |
|---|---|
| Basis of Allotment Date* | 24th May 2023 |
| Refunds Initiation* | 25th May 2023 |
| Credit of Shares to Demat* | 26th May 2023 |
| SME IPO Listing Date* | 29th May 2023 |
* - Tentative Dates
| SME IPO Activity | Date |
|---|---|
| Issue Price | ₹1150-1229 |
| Market Lot: | 100 Shares |
| 1 Lot Amount: | ₹122900 |
| Min HNI Lots: | 200 shares (2 lots) |
| GMP Date | IPO Price | GMP | Sub2 Sauda Rate | Expected Listing Gain | Last Updated |
|---|---|---|---|---|---|
| 29-05-2023 | 1229 | 575 | 55000 | ₹1804 (46.79%) | 29-May-2023 9:00 |
Zerodha Trade@20
**The GMP prices shown here are only news related to the grey market. We do not trade/deal in grey market or subject to rates (sub2), nor do we recommend trading in grey market.
Remus Pharmaceuticals Limited was established in the year 2015. The company is engaged in the marketing and distribution of finished dosage formulations. This company also deals in API (Active Pharmaceutical Ingredient). They also provide technical consultancy services to various distributors for preparing dossier reports of products to be registered by them in various countries.
Their product portfolio comprises of vide range of therapeutic drugs namely ACE inhibitors, Analgesic, anaesthetic, Antiulcer, Anti angiogenic, Anti Erectile Dysfunction, Anti fibrinolytic, Anti histamine, Anti-inflammatory, Anti-ulcer, Anti-acne, Antianxiety, Antiarrhythmic, antiarrhythmic agent, Antibiotic, Antibiotic, Anticancer, Anticholinergics, Anticoagulant, Anticonvulsant, Antidepressant, Antidiabetic, Antidiuretics, Antiemetics, Antifungal, Anti-gastric, Antihistaminic, Antihypertensive, Antimalarial, Antioxidants, Antiparasitic, Antiprotozoal, Antipsychotic, Antipyretic, Antiretroviral, Antiretrovirals, Anti-seizure, Antispasmodic, Anti-vertigo, Antiviral, Asthma, Avitaminosis, Beta blocker, Carcinoid tumours, Chronic Obstructive Pulmonary Disease, CNS stimulants, Contrast Reagent, Corticosteroids, Corticosteroids, Dermatology, Hyperprolactinemia, Immuno-suppressive, Iron chelator (binder), Iron deficiency, Menopausal hormone therapy, Mucolytic, Nasal decongestants, non-depolarizing neuromuscular blocker, NSAIDs, Ocular-hypertension, Opioid Antagonists, Phosphate binders, Potassium deficiency, Probiotic, selective relaxant binding agent, Urology, Vaso constrictor and Vitamin deficiency.
Remus Healthcare’s Core business can be divided in following categories:
| Incorporation | Sector | IPO Issue Size | Website |
| 2015 | Pharmaceutical Industry | ₹47.69 Cr | http://www.remuspharma.com/ |
The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:
The table below is live update of SME IPO bidding details from NSE and BSE.
| Day | QIB | NII | RII | Total | |
|---|---|---|---|---|---|
| # of Shares Offered | 138,750 (50%) | 41,625 (15%) | 97,125 (35%) | 277,500 | |
| 1 | 17th May 2023 19:31 | 0.00x | 2.85x | 2.85x | 1.43x |
| 2 | 18th May 2023 19:31 | 1.48x | 12.25x | 10.93x | 6.41x |
| 3 | 19th May 2023 19:31 | 10.75x | 229.31x | 49.81x | 57.21x |
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31-Mar-20 | 530.36 | 1,276.89 | 81.16 | 202.03 | 201.03 | 35.93 |
| 31-Mar-21 | 1,104.96 | 1,922.45 | 102.58 | 304.61 | 303.61 | 27.89 |
| 31-Mar-22 | 1,590.93 | 2,543.71 | 338.57 | 643.17 | 543.17 | 19.17 |
| 31-Dec-22 | 3,352.96 | 3,361.20 | 643.90 | 1,712.07 | 1,603.57 | 947.45 |
| Amount in ? Lakhs | ||||||
The table below show peer comparison from DRHP/RHP.
| Company | EPS Basic | EPS Diluted | NAV | P/E(x) | RoNW | Financial statements |
|---|---|---|---|---|---|---|
| Remus Pharmaceuticals Limited | 33.86 | 64.3 | 52.64 | Standalone | ||
| Trident Lifeline Limited | 6.92 | 5.97 | 21.46 | 82.66 | Standalone | |
| Vaishali Pharma Limited | 3.82 | 24.99 | 42.68 | 15.27 | Standalone | |
| Chandra Bhagat Pharma Limited | 1.06 | 35.35 | 99.06 | 2.99 | Standalone |
Last Updated on 01-Jun-2023 09:00:13
Zerodha allows to apply online in IPOs via their back office software "console". UPI payment mode is to be used to apply online through Zerodha. To purchase Remus Pharmaceuticals SME IPO with Zerodha, you must be Zerodha customer and have UPI payment setup. For more details please visit detailed article Step by Step Guide to apply Remus Pharmaceuticals SME IPO with Zerodha.
Alternate approch to apply in Remus Pharmaceuticals SME IPO is ASBA. You can use Zerodha DP information and apply online via ASBA with your prefered net banking user id.
Remus Pharmaceuticals SME IPO Review and Important Updates
Other relevant questions :
How to subscribe Remus Pharmaceuticals SME IPO Zerodha? How to purchase Remus Pharmaceuticals SME IPO on Zerodha? Remus Pharmaceuticals SME IPO how to buy Zerodha? Remus Pharmaceuticals SME IPO Zerodha apply. Remus Pharmaceuticals SME IPO purchase Zerodha. Remus Pharmaceuticals SME IPO with Zerodha. Remus Pharmaceuticals SME IPO at Zerodha. Remus Pharmaceuticals SME IPO kite Zerodha. Remus Pharmaceuticals SME IPO using Zerodha. Remus Pharmaceuticals SME IPO via Zerodha.
To subscribe or apply in Remus Pharmaceuticals SME IPO, you can use the following methods:
| Remus Pharmaceuticals SME IPO Applying Mode | Method | Details |
| Online Application | 3-in-1 Trading Account | If your broker is 3-in-1 service provider, you can apply in Remus Pharmaceuticals SME IPO directly with your brokers website. Example HDFC Securities, ICICI Direct, AxisDirect are 3-in-1 brokers provide you direct IPO investment. |
| Online Application | 2-in-1 Trading Account | Brokers like Zerodha, TradeSmart Online provides access to applying in Remus Pharmaceuticals SME IPO with their in-house developed platform. You need to apply in IPO via UPI payment method. You must have access of your UPI mandate to apply in IPO online. |
| Online Application | ASBA | This is one of the most popular mode of applying in Remus Pharmaceuticals SME IPO. Most of the Syndicate Banks provide access to apply in Remus Pharmaceuticals IPO via ASBA process. You must have your net banking access, DP ID information to apply in Remus Pharmaceuticals SME IPO via ASBA. Bank like Axis, SBI allows you to apply maximum 5 application from one bank account. However, ICICI, HDFC bank have limit of one IPO ASBA application per account. |
| Offline Application | Physical Form | You can apply in Remus Pharmaceuticals SME IPO via physical form, but not with ASBA. Physical Forms need to be filled using UPI mode of payment and need to approve the mandate of UPI with your registered phone number with your UPI provider. You can use BHIM app or banks mobile app who support UPI process like SBI, HSBC, Axis, ICICI, HDFC, Yes Bank, Citi Bank mobile app. |
Remus Pharmaceuticals SME IPO Review and Important Updates
Other relevant question on same topics are:
Where to subscribe Remus Pharmaceuticals SME IPO? Where to apply for Remus Pharmaceuticals SME IPO? How to subscribe Remus Pharmaceuticals SME IPO online? Remus Pharmaceuticals SME IPO where to apply? Where to buy Remus Pharmaceuticals SME IPO online? How to buy Remus Pharmaceuticals SME IPO online? How to purchase Remus Pharmaceuticals SME IPO? How to get Remus Pharmaceuticals SME IPO? How to book Remus Pharmaceuticals SME IPO? How to invest Remus Pharmaceuticals SME IPO? Remus Pharmaceuticals SME IPO kaise buy kare?
Remus Pharmaceuticals SME IPO is going to be list on 29-05-2023. NSE Code for Remus Pharmaceuticals is REMUS. BSE Code for Remus Pharmaceuticals is .
Other relevant questions:
When Remus Pharmaceuticals SME IPO will be listing? Remus Pharmaceuticals SME IPO NSE listing date?Remus Pharmaceuticals SME IPO date of listing.Remus Pharmaceuticals SME IPO BSE listing date?
Remus Pharmaceuticals SME IPO Allotment Date is 24-05-2023.
Other relevant questions:
Remus Pharmaceuticals SME IPO share allotment date?Remus Pharmaceuticals SME IPO allotment date?
